23.06.2025, 12:59

Polpharma to invest $62.6 mln in expansion of ChimPharm plant in Kazakhstan

ASTANA. June 23 (Interfax-Kazakhstan) - Polpharma Group will invest $62.6 million to expand the production capacity of its subsidiary ChimPharm JSC (SANTO), a pharmaceutical plant located in Shymkent, the press service of Kazakhstan’s government said in a Monday statement.

To read the full news articles, Subscribe.

05:10PM
Kazakhstan to issue 2 dollar-denominated Eurobond issues with 7-, 12-year maturities, listing to take place on LSE, AIX, KASE

05:02PM
Kazakh President instructs to strengthen offense prevention

04:52PM
Kazakhstan aims to improve anti-money laundering practices to meet global standards

04:29PM
Interfax-Kazakhstan issues its 1066th Oil&Gas Report

04:05PM
AVERAGE WEIGHTED RATE ON JUNE 23, 2025 IS 523.46 TENGE FOR $1

04:03PM
Kazakhstan concerned over potential logistics disruptions amid Iran tensions

03:36PM
Supply of raw gas from Urikhtau field to Zhanazhol plant to begin in Q4

03:10PM
KazAvtoZhol and EBRD sign deal to fund modernization of Aktobe-Ulgaisyn highway

02:36PM
U.S. strikes on Iran cause huge damage to authority of NPT, IAEA's verification system based on it - Russian Foreign Ministry

02:35PM
U.S. strikes on Iran could lead to Washington's involvement in protracted conflict, further oil price hikes - Russian expert

02:32PM
Kazakh minister warns AIFC risks becoming domestic offshore zone, causing tax losses (Part 2)